Incyte’s skin disease drug shows long-term symptom relief

Incyte said on Saturday its experimental skin disease drug showed long-term reduction of symptoms in two late-stage trials. The ​company tested the drug, povorcitinib, in patients with ‌moderate to severe hidradenitis suppurativa, a chronic skin disease that causes painful lumps, abscesses and scarring, usually in areas where skin rubs ​together like the armpits or groin. […]